At the highest doses, retatrutide seems to promise more significant weight loss than existing GLP-1s on the market but as dosage increases, so does the risk of side effects, mostly mild-to-moderate gastrointestinal issues, although one case of pancreatitis occurred in a patient on the 12mg dose during the phase II trial
A key strength of this study is its validation of clinical trial findings in a real-world setting using a large sample size
In central sensitization, the spinal cord and brain amplify incoming signals regardless of their original intensity
Melanotan II should not be administered indefinitely or continuously, regardless of the research application
Any cloudiness, milkiness, or visible turbidity indicates either bacterial contamination or peptide aggregation, both of which render the solution unusable